Ironwood Pharmaceuticals (IRWD) Non-Current Assets (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 17 years of Non-Current Assets data on file, last reported at $102.3 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 38.62% year-over-year to $102.3 million; the trailing twelve-month figure through Mar 2026 stood at $498.4 million (down 34.72% YoY), and the FY2025 full-year result was $122.7 million, down 27.18% from the prior year.
• Non-Current Assets eased to $102.3 million in Q1 2026, from $122.7 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $373.3 million in Q1 2022 to a low of $102.3 million in Q1 2026.
• A 5-year average of $233.4 million and a median of $230.6 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets jumped 510.95% in 2022 and plunged 42.05% in 2025, its largest moves.
• Tracing IRWD's Non-Current Assets over 5 years: stood at $319.9 million in 2022, then fell by 25.67% to $237.8 million in 2023, then slipped by 29.12% to $168.5 million in 2024, then fell by 27.18% to $122.7 million in 2025, then retreated by 16.66% to $102.3 million in 2026.
• Business Quant data shows IRWD's Non-Current Assets at $102.3 million in Q1 2026, $122.7 million in Q4 2025, and $122.2 million in Q3 2025.